Diuretics for treatment of hypertension: Critical analysis of opinions of French general practitioners and cardiologists;LES DIURETIQUES DANS LE TRAITEMENT DE HYPERTENSION ARTERIELLE: ANALYSE CRITIQUE DE L'OPINION DES PRATICIENS GENERALISTES ET CARDIOLOGUES

Therapie

Volumn 51, Issue 1, 1996, Pages 49-55

  Charansonney, O L ^a   Saint Paul, D ^b   Doan Tran, D ^a   Dreyfus, J P ^b   Grunfeld, J P ^c  

^a Laboratoires Hoechst   (France)

^b SOFRES Medical   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Clinical practice; Clinical trials impact; Diuretics; Hyrertension

Indexed keywords

CICLETANINE; DIURETIC AGENT; INDAPAMIDE; PIRETANIDE;

ARTICLE; DRUG EFFICACY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; CARDIOLOGY; DRUG INDUSTRY; DRUG INFORMATION; GENERAL PRACTITIONER; STATISTICS;

CARDIOLOGY; DIURETICS; DRUG INDUSTRY; DRUG INFORMATION SERVICES; HUMANS; HYPERTENSION; PHYSICIANS, FAMILY;

EID: 0029693647     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. MRC working party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97-104.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
3. MRC Working Party. Medical research council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
4. The Guidelines Subcommittee of The WHO/ISH. 1993 Guidelines for the Management of Mild Hypertension. Memorandum From a World Health Organization/International Society of Hypertension Meeting. Hypertension 1993; 22: 392-403.
5. Avenant no 1 à la convention médicale, 18 février 1994. Droit et Pharmacie 1 mars 1994: 1-25.
6. Grosbras JM. Méthodes statistiques de sondages. Paris: Edition Economica, 1987 (1 volume).
7. Smith TMF. On die validity of interferences from non-random samples. J R Stat Soc A 1983; 146: 394-403.
8. Deville J-C. Eléments pour une théorie des enquêtes par quotas. In: La qualité de l'information dans les enquêtes. Association pour la statistique et ses utilisations. Paris: Dunod, 1992: 345-364.
9. Kannel WB. Hypertension as risk factor for cardiac events - Epidemiologic results of long-term studies. J Cardiovasc Pharmacol 1993; 21 (suppl 2): S27-S37.
10. Jouve R, Ebagosti A, Blanc MM, Costa G, Serradimigni A, Jouve A. Prévalence de l'hypertension artérielle et son traitement chez 2 595 adultes. Arch Mal Coeur 1988; 81 (suppl HTA): 159-164.
11. Dictionnaire Vidal. Paris: éditions du Vidai, 1993.
12. Imbs J-L, Stephan D, Grima M. Diurétiques. Encycl Méd Chir (Paris, France), Therapeutique 1994; 25-355-B-20, 11 p.
13. Joint National Committee. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
14. Dictionnaire Vidal. Paris: édition du Vidal, 1995.
15. Clinical trials and clinical practice. Lancet 1993; 342 (8876): 877-878.
16. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet 1993; 342: 891-894.
17. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos ChL, McNeil BJ. Knowledge and practice of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl Engl J Med 1994; 331: 1136-1142.
18. Avenant no 5 à la convention médicale. Journal officiel de la République française mars 1995: 3493-3504.
19. Boissel JP, Groupe VALIDATA. L'information thérapeutique: comment transmettre les données actuelles de la science. Therapie 1994; 49: 299-311.